Skip to content

Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge

The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.

What’s Keeping the US From Allowing Better Sunscreens?

A decade after Congress told the FDA to expedite the approval of more effective sunscreens, the federal government still has not approved sunscreen ingredients that are safely being used around the world. Meanwhile, skin cancer is the nation’s most common cancer.

Listen to the Latest ‘KFF Health News Minute’

“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.

Biden Team’s Tightrope: Reining In Rogue Obamacare Agents Without Slowing Enrollment

Federal regulators face a growing challenge — how to prevent rogue health insurance agents from switching unknowing consumers’ Obamacare coverage without making the enrollment process so cumbersome that enrollment declines.

Could Better Inhalers Help Patients, and the Planet?

Puff inhalers can be lifesavers for people with asthma and other respiratory diseases, but some types release potent greenhouse gases that contribute to climate change. That, in turn, worsens wildfires, contributes to air pollution, and intensifies allergy seasons — which can increase the need for inhalers. Some doctors are helping patients switch to more eco-sensitive inhalers.

2020 Coverage of Rubber Bullets

Weekly Podcast

KFF Health News' 'What the Health?': Abortion Access Changing Again in Florida and Arizona

Daily Cartoon

‘To Pee or Not to Pee?’

Used with the permission of Doug Hill. Cartoons are the property of their respective artists and are subject to copyright laws. Do not reproduce or redistribute this cartoon without permission of the artist.

View All Cartoons